SLC1A5 and hepatocellular carcinoma: In HCC, a transmembrane receptor tyrosine kinase named Discoid protein domain receptor 1 (DDR1) interacts with SLC1A5, regulates its stability, and thereby affects its downstream target, mTORC1 in increasing HCC progression [52].